Related Experiment Video
Updated: Aug 5, 2025

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.7K
miR-4432 Targets FGFBP1 in Human Endothelial Cells
Roberta Avvisato1,2,3, Pasquale Mone1,2, Stanislovas S Jankauskas1,2
1Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY 10461, USA.
Biology
|March 29, 2023
Summary
MicroRNAs (miRs) regulate gene expression. This study identifies miR-4432 as a key regulator of FGFBP1, reducing oxidative stress in brain endothelial cells and offering potential hypertension insights.
Area of Science:
- Molecular Biology
- Neuroscience
- Cardiovascular Research
Background:
- MicroRNAs (miRs) are small non-coding RNAs regulating gene expression.
- Fibroblast growth factor binding protein 1 (FGFBP1) is linked to blood-brain barrier (BBB) endothelial dysfunction.
- Mechanisms connecting miRs and FGFBP1 in BBB dysfunction remain largely unknown.
Purpose of the Study:
- To identify and validate specific microRNAs targeting FGFBP1 in human brain microvascular endothelial cells.
- To investigate the functional role of identified miRs in regulating FGFBP1 expression.
- To explore the impact of miR-FGFBP1 interaction on cellular processes relevant to BBB function and hypertension.
Main Methods:
- Utilized human brain microvascular endothelial cells as an in vitro model of the BBB.
- Employed techniques to identify and validate microRNA targets of FGFBP1.
- Assessed the effect of miR-4432 on FGFBP1 expression and mitochondrial oxidative stress.
Main Results:
- Successfully identified and validated miR-4432 as a direct targeting microRNA of FGFBP1.
- Demonstrated that miR-4432 significantly downregulates FGFBP1 expression.
- Showed that miR-4432 reduces mitochondrial oxidative stress in brain endothelial cells.
Conclusions:
- miR-4432 is a critical modulator of FGFBP1 in the context of the BBB.
- miR-4432 exerts protective effects by mitigating mitochondrial oxidative stress.
- This finding provides a novel molecular link between miRs, FGFBP1, and hypertension pathophysiology at the BBB.

